Trials / Completed
CompletedNCT04125771
Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Aljazeera Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Diclofenac is a proven, commonly prescribed nonsteroidal anti-inflammatory drug (NSAID) that has analgesic, anti-inflammatory, and antipyretic properties, and has been shown to be effective in treating a variety of acute and chronic pain and inflammatory conditions.
Detailed description
Diclofenac is a proven, commonly prescribed nonsteroidal anti-inflammatory drug (NSAID) that has analgesic, anti-inflammatory, and antipyretic properties, and has been shown to be effective in treating a variety of acute and chronic pain and inflammatory conditions. . As with all NSAIDs, diclofenac exerts its action via inhibition of prostaglandin synthesis by inhibiting cyclooxygenase-1 (COX-1)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Diclofenac + HBB with hysteroscopy | Giving Diclofenac + HBB with hysteroscopy |
| DIAGNOSTIC_TEST | Diclofenav + placebo | Giving Diclofenac + placebo with hysteroscopy |
Timeline
- Start date
- 2020-02-16
- Primary completion
- 2020-08-25
- Completion
- 2020-10-01
- First posted
- 2019-10-14
- Last updated
- 2021-11-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04125771. Inclusion in this directory is not an endorsement.